IPO action brief: TP joins, CSQR leads the week
Ticketplus is the fresh US IPO watch name for July 13, while Csquare and Standard Nuclear remain the larger week-ahead deals. No mainstream US retail broker allocation window was publicly verified, and Hong Kong is no-action after EKH's cancelled listing.
Ticketplus is the only fresh US name on today's board. It is small, profitable on trailing numbers, and tied to a simple consumer story: live-event ticketing in Latin America. The catch is just as simple: I could not verify a mainstream US broker retail allocation window for TP, CSQR, STDN, or TARX before publication.
July 13 is a normal NYSE trading day. The NYSE 2026 holiday calendar shows Independence Day observed on July 3 and Labor Day on September 7 as the next full market holiday. 1
Today's spotlight: Ticketplus
Ticketplus is a Chile-based live-event ticketing and event-software company. It sells a full-stack platform for event discovery, primary ticketing, access control, payments, analytics, and post-event insights. 2
Why it matters: this is not a data-center mega deal, but it is easier for retail investors to understand. The pitch is live events plus software, with a Latin America angle. IPOScoop lists Ticketplus at 1.8 million shares, a $13-$15 range, and about $25 million of expected volume. 3
The headline number: StockAnalysis shows Ticketplus with $29.46 million in trailing revenue and $2.24 million in trailing net income. That does not make the stock cheap. At the low end of the IPO range, StockAnalysis shows a market cap around $174.8 million, so investors are paying for growth and scarcity, not just current earnings. 4
The main risk: the SEC filing says Ticketplus is a Cayman Islands issuer, a foreign private issuer, and an emerging growth company. It also says one director held about 76.1% of voting power before the offering. That control setup matters because small IPOs can trade on story first and governance second. 2
Subscription status: watch-only unless your broker shows a live order ticket. IPOScoop lists TP as expected to trade in the week of July 13, not as a verified public retail allocation available through Robinhood, Fidelity, Schwab, E*TRADE, or Webull. 5
Actionable now
No publicly verified mainstream US retail IPO allocation window was found for this issue. Treat these as calendar and broker-watch names, not open retail orders.
| Name | Ticker | Terms | Status today | Retail access read |
|---|---|---|---|---|
| Ticketplus | TP | $13-$15; 1.8M shares; about $25M | Expected to trade in the week of July 13 3 | Watch-only unless your broker shows a ticket |
| Tarsier Pharma | TARX | $8-$10; 5.0M shares; about $45M | Expected to trade July 15 6 | Watch-only |
| Csquare | CSQR | $23-$27; 50.0M shares; about $1.25B | Expected to trade July 16 7 | Watch for broker access; not confirmed open today |
| Standard Nuclear | STDN | $18-$21; 18.3M shares; about $355.9M | Expected to trade July 16 8 | Watchlist only |
Market pulse
- The big-money week is still CSQR and STDN. Renaissance Capital says Csquare is set to raise $1.25 billion and Standard Nuclear is set to raise $356 million in the week ahead. Ticketplus adds a smaller retail-friendly story, but it is not the week's size leader. 9
- Csquare has the AI-infrastructure hook, plus debt risk. Renaissance says Csquare operates 64 facilities across 21 major US metropolitan markets and improved adjusted EBITDA margin to 40% in the last 12 months, but it also flags leverage at 12.1x net debt to LTM adjusted EBITDA. 10
- Standard Nuclear has the nuclear theme, plus supply-chain risk. Renaissance says the company has a contract backlog of up to $245 million, but its manufacturing depends on customers getting enriched uranium feedstock, including HALEU, where the note says there is no commercial supply in the US. 10
HK desk
Hong Kong is also no-action for live public subscription today. ET Net's IPO timetable shows no related information under live listing IPOs, and its listed-today section shows EKH as cancelled. 11
EKH had previously shown an application period from June 30 to noon on July 8, an offer range of HK$2.20-HK$2.68, a board lot of 2,000 shares, and a planned July 13 listing date; the same ET Net detail page now marks the July 13 listing as cancelled. 12
On the radar
| Name | Ticker | Date to watch | Why it matters |
|---|---|---|---|
| Ticketplus | TP | Week of July 13 | Small live-events software IPO; profitable on trailing numbers, but control and liquidity risk matter. 4 |
| Tarsier Pharma | TARX | July 15 | Tiny biotech deal; the main question is drug-development risk, not just IPO pricing. 6 |
| Csquare | CSQR | July 16 | Data-center exposure, $1.25B deal size, and heavy leverage make it the institutional headline. 13 |
| Standard Nuclear | STDN | July 16 | Nuclear fuel is an easy retail theme, but the HALEU supply question is central. 10 |
Bottom line: TP is the fresh watch name, CSQR is still the size leader, and no verified broker allocation window is open. Check your broker's live IPO center before placing any order. This is not investment advice; IPO availability and allocation rules vary by broker.
References
- 1NYSE holidays and trading hours
nyse.com
- 2Ticketplus Form F-1
sec.gov
- 3IPOScoop Ticketplus profile
iposcoop.com
- 4StockAnalysis Ticketplus overview
stockanalysis.com
- 5IPOScoop IPO calendar
iposcoop.com
- 6IPOScoop Tarsier Pharma profile
iposcoop.com
- 7IPOScoop Csquare profile
iposcoop.com
- 8IPOScoop Standard Nuclear profile
iposcoop.com
- 9Renaissance Capital IPO calendar
renaissancecapital.com
- 10Renaissance Capital week-ahead IPO note
renaissancecapital.com
- 11ET Net Hong Kong IPO page
etnet.com.hk
- 12ET Net EKH IPO detail
etnet.com.hk
- 13Renaissance Capital Csquare profile
renaissancecapital.com
This story was produced automatically by a channel. One sentence is all it takes for Neodrop to keep producing for you.